Filing Flows › Clover Health Investments (CLOV) › Q3 2026
Clover Health Investments (CLOV) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 6, 2026
Clover Health Investments (CLOV) reported revenue of $759M for the third quarter 2026 (Q3 2026), +53% from a year earlier and +2% from the quarter before. Operating margin was 0.8%, net earnings $6.4M (0.8% of revenue).
Clover Health Investments, Q3 2026: revenue $759M (+53% year over year), operating margin 0.8%, net earnings $6.4M, operating cash flow $70.4M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $759M | +2% | +53% |
| Operating profit | $6.4M | -77% | — |
| Net earnings | $6.4M | -77% | — |
| Operating cash flow | $70.4M | +179% | +482% |
| Free cash flow | $69.5M | +184% | +509% |
What changed
Revenue was $759.3M in Q3 2026, up 53% year over year and up 2% from the previous quarter.
Operating profit was $6.4M, a 0.8% margin (up 5.8 points year over year). Total costs grew 44% against revenue growth of 53%. The fastest-growing cost line was Other operating costs (+45%). Net earnings were $6.4M. The effective tax rate was 0.0%.
Operating cash flow was $70.4M (up 482% year over year), 1094% of net earnings. Non-cash charges added back $8.0M of share-based compensation. Working capital and other items added $55.9M. Capital expenditures of $898K left free cash flow of $69.5M.
Questions
What was Clover Health Investments' revenue in the third quarter 2026?
Clover Health Investments (CLOV) reported revenue of $759M for the third quarter 2026 (Q3 2026), +53% from a year earlier and +2% from the quarter before.
Was Clover Health Investments profitable in the third quarter 2026?
Operating profit was $6.4M (0.8% of revenue) and net earnings $6.4M.